Literature DB >> 9546076

Applications of green fluorescent protein as a marker of retroviral vectors.

E S Kandel1, B D Chang, B Schott, A A Shtil, A V Gudkov, I B Roninson.   

Abstract

The Green Fluorescent Protein (GFP) of Aequorea victoria is used as a vital fluorescent tag for the detection and isolation of genetically modified cells. Several modified variants of GFP were tested as marker genes in retroviral vectors containing different backbones and promoter combinations. Constructs allowing for reliable detection of GFP fluorescence and the expression of a cotransduced gene from a strong promoter were identified. Cells harboring such constructs are detectable by flow cytometry, fluorescence microscopy and multi-well fluorescence reading. GFP expression in transduced cells is stable both in vitro and in vivo, and long-term dynamics of GFP-positive fractions in a mixed population can be used to monitor the biological effects of a cotransduced gene. Selection of cells with the highest GFP fluorescence enriches for multiply infected cells. The use of different GFP variants allows one to monitor simultaneously two cell populations transduced with vectors carrying GFPs that differ in their fluorescence intensity or spectral properties and to identify doubly transduced cells. In addition, transcription of an inducible promoter positioned in the opposite orientation to GFP can be monitored by the inhibition of GFP fluorescence. Thus, GFP provides a useful marker for gene transfer by retroviral vectors and extends the range of applications for retroviral transduction.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9546076     DOI: 10.1007/BF02674280

Source DB:  PubMed          Journal:  Somat Cell Mol Genet        ISSN: 0740-7750


  9 in total

1.  Activation of Akt/protein kinase B overcomes a G(2)/m cell cycle checkpoint induced by DNA damage.

Authors:  Eugene S Kandel; Jennifer Skeen; Nathan Majewski; Antonio Di Cristofano; Pier Paolo Pandolfi; Claudine S Feliciano; Andrei Gartel; Nissim Hay
Journal:  Mol Cell Biol       Date:  2002-11       Impact factor: 4.272

2.  Paradoxical suppression of cellular senescence by p53.

Authors:  Zoya N Demidenko; Lioubov G Korotchkina; Andrei V Gudkov; Mikhail V Blagosklonny
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-10       Impact factor: 11.205

3.  Mutagenesis by reversible promoter insertion to study the activation of NF-kappaB.

Authors:  Eugene S Kandel; Tao Lu; Youzhong Wan; Mukesh K Agarwal; Mark W Jackson; George R Stark
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-25       Impact factor: 11.205

4.  Quantifying pharmacologic suppression of cellular senescence: prevention of cellular hypertrophy versus preservation of proliferative potential.

Authors:  Zoya N Demidenko; Mikhail V Blagosklonny
Journal:  Aging (Albany NY)       Date:  2009-12-31       Impact factor: 5.682

5.  In vitro osteogenic differentiation of adipose stem cells after lentiviral transduction with green fluorescent protein.

Authors:  Qian Wang; Megan B Steigelman; John A Walker; Shuo Chen; Peter J Hornsby; Mary E Bohnenblust; Howard T Wang
Journal:  J Craniofac Surg       Date:  2009-11       Impact factor: 1.046

6.  The response to PAK1 inhibitor IPA3 distinguishes between cancer cells with mutations in BRAF and Ras oncogenes.

Authors:  Ruchi Singhal; Eugene S Kandel
Journal:  Oncotarget       Date:  2012-07

7.  FOXO1 regulates expression of a microRNA cluster on X chromosome.

Authors:  Ruchi Singhal; Jonathan E Bard; Norma J Nowak; Michael J Buck; Eugene S Kandel
Journal:  Aging (Albany NY)       Date:  2013-05       Impact factor: 5.682

8.  Peroxiredoxin 1 stimulates endothelial cell expression of VEGF via TLR4 dependent activation of HIF-1α.

Authors:  Jonah R Riddell; Patricia Maier; Stephanie N Sass; Michael T Moser; Barbara A Foster; Sandra O Gollnick
Journal:  PLoS One       Date:  2012-11-21       Impact factor: 3.240

9.  A natural human retrovirus efficiently complements vectors based on murine leukemia virus.

Authors:  Beihua Dong; Robert H Silverman; Eugene S Kandel
Journal:  PLoS One       Date:  2008-09-04       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.